- Special Meeting of Stockholders to approve Reverse Stock Split scheduled for March 2, 2020
- Preliminary Proxy Statement filed with the U.S. Securities and Exchange Commission
WESTBOROUGH, Mass. –
Kopin Corporation (NASDAQ:KOPN), a leading developer of innovative wearable computing technologies and solutions, today announced that its Board of Directors has approved a proposal, to be submitted to stockholders for approval at a Special Meeting of Stockholders anticipated to be held on March 2, 2020, to authorize the Board of Directors to effect a reverse stock split of the Company’s common stock. The reverse stock split proposal is subject to stockholder approval and includes a proposed range between 1-for-2 and 1-for-20 shares of outstanding common stock. The final ratio will be determined by Kopin’s Board of Directors or a duly authorized committee thereof after stockholder approval. The price of each common share is expected to increase so that a stockholder would have fewer but higher priced shares. A reverse stock split would not have any impact on the voting and other rights of stockholders and will have no impact on the Company’s business operations.
The reverse stock split is intended to enable Kopin to regain full compliance with the Nasdaq listing rules. As previously announced, Kopin will regain compliance with the Nasdaq share price listing rule if at the last trading day of any month during the six-month cure period, or at April 6, 2020, the end of the six-month cure period, the Company has at least a $1.00 share price and has maintained at least a $1.00 average closing share price over the preceding 10 consecutive business days. Kopin’s common stock continues to be listed on the Nasdaq and will continue to trade as usual during the six-month cure period.
Kopin Corporation filed a preliminary proxy statement with the U.S. Securities and Exchange Commission as required by the SEC rules. The proposal requires the affirmative vote of a majority of the Company’s outstanding shares entitled to vote. Stockholders may obtain a free copy of the preliminary proxy statement and other documents that the Company files with the SEC at the SEC’s website at www.sec.gov. The Company will file with the SEC and distribute to its stockholders a definitive proxy statement regarding the special meeting and the reverse stock split proposal. The Company will issue another press release when the definitive proxy statement is filed.
Kopin Corporation is a leading developer and provider of innovative wearable technologies and critical components for integration into wearable computing systems for military, industrial and consumer products. Kopin’s technology portfolio includes ultra-small displays, optics, speech enhancement technology, and low-power ASICs. For more information, please visit Kopin’s website at www.kopin.com.
Statements in this press release may be considered “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended (the “Securities Act”), and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), which are subject to the safe harbor created by such sections. Words such as “expects,” “believes,” “can,” “will,” “estimates,” and variations of such words and similar expressions, and the negatives thereof, are intended to identify such forward-looking statements. We caution readers not to place undue reliance on any such “forward-looking statements,” which speak only as of the date made, and advise readers that these forward-looking statements are not guarantees of future performance and involve certain risks, uncertainties, estimates, and assumptions by us that are difficult to predict. These forward-looking statements may include our expectation that the price of our common shares are expected to increase. Various factors, some of which are beyond our control, could cause actual results to differ materially from those expressed in, or implied by, such forward-looking statements. All such forward-looking statements, whether written or oral, and whether made by us or on our behalf, are expressly qualified by these cautionary statements and any other cautionary statements that may accompany the forward-looking statements. In addition, we disclaim any obligation to update any forward-looking statements to reflect events or circumstances after the date of this press release, except as may otherwise be required by the federal securities laws. These forward-looking statements are only predictions, subject to risks and uncertainties, and actual results could differ materially from those discussed. Important factors that could affect performance and cause results to differ materially from management’s expectations are described in Part I, Item 1A. Risk Factors; Part II, Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations; and other parts of our Annual Report on Form 10-K for the fiscal year ended December 29, 2018, as amended by Amendment No. 1 thereto on Form 10-K/A filed on November 7, 2019 or as updated from time to time in the Company’s Securities and Exchange Commission filings.